Document is current
Any future updates will be listed below
-
Authors
Witus, Samuel R. https://orcid.org/0000-0003-1907-8484
Kober, Megan M. https://orcid.org/0000-0003-3909-9573
Roh, Heegwang https://orcid.org/0000-0002-1549-2437
Yang, Zhi https://orcid.org/0000-0001-8680-3784
Choueiry, Fouad https://orcid.org/0009-0002-3350-8217
Ghate, Avani S. https://orcid.org/0009-0003-5781-3176
Titov, Denis V. https://orcid.org/0000-0001-5677-0651
Rapé, Michael https://orcid.org/0000-0003-4849-6343
- License Information
-
More Information
Article History
Received: 29 August 2025
Accepted: 2 June 2026
First Online: 15 July 2026
Ethics
Competing interests: M.R. is a co-founder and scientific advisory board member of Nurix Therapeutics; co-founder, consultant and scientific advisory board member of Lyterian Therapeutics; co-founder and consultant of Zenith Therapeutics; co-founder of Reina Therapeutics; and iPartner at The Column Group. The remaining authors declare no competing interests.
